Alexis Desrichard
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 6
- Peptidase Inhibition and Analysis 4
- Otorhinolaryngology top 2%
- Immunology top 5%
- Immunotherapy and Immune Responses 4
- interferon and immune responses 2
- Immune Cell Function and Interaction 2
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 3
-
- Lung Cancer Treatments and Mutations 3
-
- Genomics and Rare Diseases 2
- Co-authors
- Timothy A. ChanNadeem RiazLuc G.T. MorrisJonathan J. HavelYasin ŞenbabaoğluA. Ari HakimiKen-Wing LeeMartin G. Dalin
- Partner nations
- United StatesFranceNetherlands
In The Last Decade
Alexis Desrichard
21 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Oncology 1.1k
- Otorhinolaryngology 169
- Immunology 746
- Cancer Research 497
- Pulmonary and Respiratory Medicine 369
Countries citing papers authored by Alexis Desrichard
This map shows the geographic impact of Alexis Desrichard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexis Desrichard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexis Desrichard more than expected).
Fields of papers citing papers by Alexis Desrichard
This network shows the impact of papers produced by Alexis Desrichard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexis Desrichard. The network helps show where Alexis Desrichard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alexis Desrichard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 10 | |
| 2 | 2019 | 27 | |
| 3 | 2018 | 121 | |
| 4 | 2017 | 234 | |
| 5 | 2017 | 76 | |
| 6 | 2016 | 135 | |
| 7 | 2016 | 101 | |
| 8 | 2016 | 42 | |
| 9 | The head and neck cancer immune landscape and its immunotherapeutic implicationsbreakdown → | 2016 | 551 |
| 10 | 2016 | 125 | |
| 11 | 2016 | 193 | |
| 12 | 2016 | 5 | |
| 13 | 2015 | 180 | |
| 14 | 2014 | 35 | |
| 15 | 2013 | 29 | |
| 16 | 2013 | 29 | |
| 17 | 2013 | 1 | |
| 18 | 2012 | 1 | |
| 19 | 2012 | 2 | |
| 20 | 2011 | 65 |
About Alexis Desrichard
Alexis Desrichard is a scholar working on Oncology, Immunology and Cancer Research, having authored 21 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Peptidase Inhibition and Analysis (4 papers), Immunotherapy and Immune Responses (4 papers), Cancer Genomics and Diagnostics (3 papers), Lung Cancer Treatments and Mutations (3 papers), Genomics and Rare Diseases (2 papers), interferon and immune responses (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Oncology (1.1k citations), Otorhinolaryngology (169 citations) and Immunology (746 citations). Alexis Desrichard has collaborated with scholars based in United States, France and Netherlands. Frequent co-authors include Timothy A. Chan, Nadeem Riaz, Luc G.T. Morris, Jonathan J. Havel, Yasin Şenbabaoğlu, A. Ari Hakimi, Ken-Wing Lee, Martin G. Dalin, Alexandra Snyder and Vladimir Makarov. Their work appears in journals such as Cell, Nature Genetics and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.